Welcome news about levodopa, but uncertainty remains

Annals of Neurology

Volumn 43, Issue 5, 1998, Pages 551-554

  Fahn, S ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; TYROSINE 3 MONOOXYGENASE;

DOPAMINERGIC NERVE CELL; DYSKINESIA; EDITORIAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEUROTOXICITY; NONHUMAN; ON OFF PHENOMENON; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANTIPARKINSON AGENTS; HUMANS; LEVODOPA; PARKINSON DISEASE;

EID: 0031969137     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430502     Document Type: Editorial

References (42)